Drug-drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding

CMAJ. Canadian Medical Association Journal

Volumn 177, Issue 4, 2007, Pages 347-351

  Delaney, Joseph A ^a   Opatrny, Lucie ^a   Brophy, James M ^a   Suissa, Samy ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; CLOPIDOGREL; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DEXKETOPROFEN; DICLOFENAC; DIFLUNISAL; DIURETIC AGENT; ETODOLAC; FENOPROFEN; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MEFENAMIC ACID; MELOXICAM; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PROTON PUMP INHIBITOR; SULINDAC; TENOXICAM; UNINDEXED DRUG; WARFARIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; RISK ASSESSMENT; SEX DIFFERENCE; UNITED KINGDOM;

EID: 34548314463     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.070186     Document Type: Article

References (19)

1. Dentali F, Douketis JD, Lim W, et al. Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials. Arch Intern Med 2007;167:117-24.
2. Scarvelis D, Wells PS. Diagnosis and treatment of deep-vein thrombosis. CMAJ 2006;175:1087-92.
3. Buresly K, Eisenberg MJ, Zhang X, et al. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med 2005;165:784-9.
4. Jonsson AK, Spigset O, Jacobsson I, et al. Cerebral haemorrhage induced by warfarin-the influence of drug-drug interactions. Pharmacoepidemiol Drug Saf 2007; 16:309-15.
5. Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ 2006;333:726.
6. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997;350:1097-9.
7. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the general practice research database. Pharmacotherapy 2003;23:686-9.
8. Lawrenson R, Williams T, Farmer R. Clinical information for research; the use of general practice databases. J Public Health Med 1999;21:299-304.
9. Gasse C, Hollowell J, Meier CR, et al. Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin. Thromb Haemost 2005;94:537-43.
10. Hollowell I, Ruigomez A, Johansson S, et al. The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom. Br J Gen Pract 2003;53:312-4.
11. Clayton D, Hills M. Statistical models in epidemiology. Oxford (UK): Oxford University Press; 1993.
12. Suissa S. Novel approaches to pharmacoepidemiology study design and statistical analysis. In: Strom BL, editor. Pharmacoepidemiology. Sussex (UK): John Wiley & Sons; 2000. p. 785-805.
13. Rothberg MB, Celestin C, Fiore LD, et al. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit. Ann Intern Med 2005;143:241-50.
14. Meade TW, Roderick PJ, Brennan PJ, et al. Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation. Thromb Haemost 1992;68:1-6.
15. Sarawate C, Sikirica MV, Willey VJ, et al. Monitoring anticoagulation in atrial fibrillation. J Thromb Thrombolysis 2006;21:191-8.
16. MacDonald TM, Morant SV, Goldstein JL, et al. Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs. Gut 2003;52:1265-70.
17. Schneider V, Levesque LE, Zhang B, et al. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based, nested case-control analysis. Am J Epidemiol 2006;164:881-9.
18. Levesque LE, Brophy JM, Zhang B. Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors. CMAJ 2006;174:1563-9.
19. Bombardier C, Laine L, Reicin A, et al.; VIGOR Study Group. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000;343:1520-8.